| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.INTIMP.2011.05.006 |
| P8608 | Fatcat ID | release_ru5kxhj65jhbhaz2howzkz4jrq |
| P932 | PMC publication ID | 3183240 |
| P698 | PubMed publication ID | 21616174 |
| P5875 | ResearchGate publication ID | 51168724 |
| P2093 | author name string | Pablo Iribarren | |
| Maria C Rodriguez-Galan | |||
| Daniela S Arroyo | |||
| Emilia A Gaviglio | |||
| Javier A Soria | |||
| P2860 | cites work | Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs | Q24303416 |
| What the Myddosome structure tells us about the initiation of innate immunity | Q24338472 | ||
| Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis | Q24645038 | ||
| Does neuroinflammation fan the flame in neurodegenerative diseases? | Q27498993 | ||
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| Alzheimer's disease: genes, proteins, and therapy | Q28131806 | ||
| TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta | Q28506630 | ||
| The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors | Q28511605 | ||
| Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis | Q28591514 | ||
| Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1 | Q28646121 | ||
| Microglia-mediated neurotoxicity: uncovering the molecular mechanisms | Q29547835 | ||
| Recognition of microorganisms and activation of the immune response | Q29617903 | ||
| Mechanisms underlying inflammation in neurodegeneration | Q29617977 | ||
| Microglial cells in astroglial cultures: a cautionary note | Q30480840 | ||
| Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain | Q30665189 | ||
| Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity | Q33594690 | ||
| Inflammation, microglia, and Alzheimer's disease | Q33664099 | ||
| Role of the innate immune system in the pathogenesis of multiple sclerosis | Q33787624 | ||
| Resveratrol differentially modulates inflammatory responses of microglia and astrocytes | Q34114119 | ||
| Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. | Q34160547 | ||
| Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis | Q34312767 | ||
| The pathogenesis of senile plaques | Q34421483 | ||
| SARM inhibits both TRIF- and MyD88-mediated AP-1 activation. | Q39725027 | ||
| An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. | Q39826521 | ||
| Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. | Q40341534 | ||
| Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon | Q40368047 | ||
| A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. | Q40657503 | ||
| Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. | Q40761654 | ||
| MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease. | Q42026763 | ||
| Preferential expression and function of Toll-like receptor 3 in human astrocytes | Q42472896 | ||
| Broad expression of Toll-like receptors in the human central nervous system | Q44492400 | ||
| Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. | Q45269970 | ||
| Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease | Q45877904 | ||
| Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes | Q46654805 | ||
| Cultured astrocytes express toll-like receptors for bacterial products | Q48235492 | ||
| What is immune privilege (not)? | Q48356667 | ||
| Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases | Q48459159 | ||
| The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. | Q48529344 | ||
| Cortical demyelination and diffuse white matter injury in multiple sclerosis. | Q48726181 | ||
| Viruses selectively upregulate Toll-like receptors in the central nervous system | Q48771055 | ||
| LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. | Q51817662 | ||
| In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. | Q54644936 | ||
| Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system | Q61709654 | ||
| Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta | Q79370162 | ||
| A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity | Q79931398 | ||
| CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein- coupled receptor mFPR2 | Q81341065 | ||
| Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis | Q81342560 | ||
| IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia | Q81375625 | ||
| The role of dendritic cells in neurodegenerative diseases. | Q34721462 | ||
| Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology | Q34943311 | ||
| Microglia as neuroprotective, immunocompetent cells of the CNS. | Q34963638 | ||
| Microglia as a source and target of cytokines | Q34963658 | ||
| Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2. | Q34975805 | ||
| Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals | Q35037100 | ||
| TLR8: an innate immune receptor in brain, neurons and axons | Q35047901 | ||
| The Toll-IL-1 receptor adaptor family grows to five members. | Q35155932 | ||
| The Increasing Burden of Alzheimer Disease | Q35544971 | ||
| Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis | Q35606759 | ||
| Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease | Q35914863 | ||
| Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits | Q35963056 | ||
| Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia. | Q36008864 | ||
| Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response | Q36098825 | ||
| Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease | Q36124489 | ||
| How Toll-like receptors signal: what we know and what we don't know | Q36339101 | ||
| The role of inflammation in CNS injury and disease | Q36364424 | ||
| Glial toll-like receptor signaling in central nervous system infection and autoimmunity | Q36440629 | ||
| The role of Toll-like receptors in CNS response to microbial challenge | Q36561142 | ||
| Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities | Q36689365 | ||
| Role of toll-like receptor signalling in Abeta uptake and clearance | Q36745996 | ||
| Toll-like receptors in inflammation, infection and cancer | Q36900602 | ||
| Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation | Q37088433 | ||
| Can the immune system be harnessed to repair the CNS? | Q37168160 | ||
| Toll-like receptors in neurodegeneration. | Q37186287 | ||
| How location governs toll-like receptor signaling | Q37341616 | ||
| Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. | Q37352700 | ||
| CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. | Q37424811 | ||
| Unique lipids from a common human bacterium represent a new class of Toll-like receptor 2 ligands capable of enhancing autoimmunity | Q37462735 | ||
| Regulation of innate immune responses in the brain | Q37492253 | ||
| A cell biological view of Toll-like receptor function: regulation through compartmentalization. | Q37531879 | ||
| Inflammation and microglia actions in Alzheimer's disease | Q37577745 | ||
| Orchestrating innate immune responses in multiple sclerosis: molecular players. | Q37764110 | ||
| Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application | Q37779740 | ||
| Evaluating the role of Toll-like receptors in diseases of the central nervous system | Q37829488 | ||
| P433 | issue | 10 | |
| P921 | main subject | toll-like receptor | Q408004 |
| neurodegeneration | Q1755122 | ||
| P304 | page(s) | 1415-1421 | |
| P577 | publication date | 2011-05-25 | |
| P1433 | published in | International Immunopharmacology | Q15751306 |
| P1476 | title | Toll-like receptors are key players in neurodegeneration | |
| P478 | volume | 11 |
| Q35837175 | ATM kinase inhibition in glial cells activates the innate immune response and causes neurodegeneration in Drosophila |
| Q33563621 | Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration |
| Q38164897 | Autophagy in inflammation, infection, neurodegeneration and cancer |
| Q48490461 | Betaine recovers hypothalamic neural injury by inhibiting astrogliosis and inflammation in fructose-fed rats |
| Q34680801 | Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target. |
| Q37656512 | Celastrol suppresses expression of adhesion molecules and chemokines by inhibiting JNK-STAT1/NF-κB activation in poly(I:C)-stimulated astrocytes |
| Q59806693 | Curative Anti-Inflammatory Properties of Chinese Optimized Yinxieling Formula in Models of Parkinson's Disease |
| Q35227177 | Death following traumatic brain injury in Drosophila is associated with intestinal barrier dysfunction. |
| Q44580754 | Drosophila innate immune response pathways moonlight in neurodegeneration |
| Q64118947 | Evidence for Sexual Dimorphism in the Response to TLR3 Activation in the Developing Neonatal Mouse Brain: A Pilot Study |
| Q47836666 | Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles |
| Q36164195 | Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study |
| Q35544629 | Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling |
| Q44064986 | Increased expression of toll-like receptor 4 on neurons after surgery in aged rats. |
| Q47270261 | Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance |
| Q38698825 | Intramembrane attenuation of the TLR4-TLR6 dimer impairs receptor assembly and reduces microglia-mediated neurodegeneration. |
| Q34243536 | Mechanically-compliant intracortical implants reduce the neuroinflammatory response. |
| Q47767037 | Nalmefene Prevents Alcohol-Induced Neuroinflammation and Alcohol Drinking Preference in Adolescent Female Mice: Role of TLR4. |
| Q35178233 | Neuropeptides and the microbiota-gut-brain axis |
| Q37019818 | Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation |
| Q61855781 | Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture |
| Q39123617 | RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration |
| Q39105980 | Sterile Neuroinflammation and Strategies for Therapeutic Intervention |
| Q64077495 | Syk and Hrs Regulate TLR3-Mediated Antiviral Response in Murine Astrocytes |
| Q38031912 | Targeting neuroinflammation for therapeutic intervention in neurodegenerative pathologies: a role for the peptide analogue of thymulin (PAT). |
| Q88197650 | The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease |
| Q38348923 | The Role of TREM2 in Alzheimer's Disease and Other Neurological Disorders. |
| Q58780967 | The Role of Toll-Like Receptor 2 and 4 Innate Immunity Pathways in Intracortical Microelectrode-Induced Neuroinflammation |
| Q38670012 | The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease |
| Q38156518 | The influence of cannabinoids on generic traits of neurodegeneration |
| Q38162221 | The innate immune system in Alzheimer's disease. |
| Q37010253 | The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE. |
| Q47575333 | Toll-Like Receptor-3 Mediates HIV-1-Induced Interleukin-6 Expression in the Human Brain Endothelium via TAK1 and JNK Pathways: Implications for Viral Neuropathogenesis. |
| Q36482922 | Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy |
| Q34094965 | Toll-like receptor 4-mediated signaling participates in apoptosis of hippocampal neurons |
| Q36960922 | Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication |
| Q54544299 | Toll-like receptors and diseases. |
| Q53687316 | Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. |
| Q64961502 | Understanding the Role of Innate Immunity in the Response to Intracortical Microelectrodes. |
Search more.